<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03098888</url>
  </required_header>
  <id_info>
    <org_study_id>CHRO cat III 2017-01</org_study_id>
    <secondary_id>N° IDRCB 2017-A00306-47</secondary_id>
    <nct_id>NCT03098888</nct_id>
  </id_info>
  <brief_title>Bronchoalveolar Lavages for Cytologic Assessment in Intensive Care Unit Patients</brief_title>
  <acronym>REA-LBA</acronym>
  <official_title>Bronchoalveolar Lavages in the Intensive Care Unit : Indications, Adverse Respiratory Effects, Contribution to Diagnosis and Therapy. A Multicenter, Prospective, Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional d'Orléans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional d'Orléans</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is known about bronchoalveolar lavages performed for cytological assessment during
      bronchial fibroscopy in critically ill patients. Frequency of use, indications, actual
      contribution to diagnosis and therapeutic decision, and complications have not been
      extensively assessed.

      The primary objective of this multi center, prospective, observational study is to describe
      the frequency of use of bronchoalveolar lavages for cytological assessement in critically ill
      patients, identify their indications, assess their contribution to diagnosis and therapeutic
      decisions, and estimate the frequency of induced respiratory events.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives will be to

        -  assess the frequency of poor quality bronchoalveolar lavages (as defined by either more
           than 5% bronchial epithelial cell count to less than 50,000 alveolar cells per mL)

        -  assess the contribution of a given bronchoalveolar lavage to the diagnostic work up

        -  assess the contribution of a given bronchoalveolar lavage results to therapeutic
           decision

        -  assess the induced short term respiratory side effects

        -  identify risk factors for poor respiratory tolerance
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 23, 2017</start_date>
  <completion_date type="Anticipated">March 23, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 23, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>quality of performed bronchoalveolar lavage</measure>
    <time_frame>72 hours</time_frame>
    <description>pathologists examining bronchoalveolar lavage specimen will classify bronchoalveolar lavage as &quot;of poor quality&quot; or of &quot;good quality&quot; based upon cytologic assessment: bronchial cell count (not more than 5%) and alveolar cell count (above 50,000/mL).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>contribution to diagnosis and/or therapeutic decision</measure>
    <time_frame>72 hours</time_frame>
    <description>Investigators will be ask to answer the following question: Did the bronchoalveolar lavage results contribute to diagnosis and/or therapeutic decision: Yes or No</description>
  </primary_outcome>
  <primary_outcome>
    <measure>frequency of use</measure>
    <time_frame>72 hours</time_frame>
    <description>the frequency of use of bronchoalveolar lavage will be describe and expressed as the proportion of patients who underwent bronchoalveoalr lavage upon the total number of patients admitted in the recruiting intensive care units during the study period</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evolution of respiratory rate</measure>
    <time_frame>24 hours</time_frame>
    <description>respiratory rate will be assessed before the bronchoalveolar lavage and 8 times during the 24 hours following the bronchoalveolar lavage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of oxygen needs</measure>
    <time_frame>24 hours</time_frame>
    <description>Oxygen needs, in L/min in patients under conventional nasal or facial oxygen therapy, or expressed in FiO2 in patients under nasal high flow oxygen or under invasive or noninvasive ventilation, will be recorded before bronchoalveolar lavage and 8 times during the following 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of tracheal intubation</measure>
    <time_frame>24 hours</time_frame>
    <description>Percentage of patients not intubated while undergoing bronchoalveolar lavage that will need intubation within 24 hours</description>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lung Diseases</condition>
  <condition>Intensive Care</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bronchoalveolar lavage</intervention_name>
    <description>bronchoalveolar lavages performed for cytological assessment in critically ill patients with lung diseases, intubated or not</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients hospitalized in intensive care unit with acute and/or chronic lung disease
        that need bronchoalveolar lavage as part of the diagnostic work up
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patient (&gt; 18 yr-old) hospitalized in intensive care unit with acute and/or
             chronic lung disease that need bronchoalveolar lavage as part of routine diagnostic
             work up

          -  patient's or family consent

        Exclusion Criteria:

          -  consent not obtained

          -  patient already included at previous bronchoalveolar lavage of during previous
             hospitalization

          -  absence of social security number

          -  age &lt; 18yr

          -  pregnant woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Toufik KAMEL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR Orléans</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Thierry BOULAIN, MD</last_name>
    <phone>33 2 38 51 44 46</phone>
    <email>thierry.boulain@chr-orleans.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aurélie Despujols</last_name>
    <phone>33 2 38 74 40 71</phone>
    <email>aurelie.despujols@chr-orleans.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU d'ANGERS</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Achile KOUATCHET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH d'ANGOULEME</name>
      <address>
        <city>Angoulême</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Christophe GRACCO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Victor DUPOUY</name>
      <address>
        <city>Argenteuil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gaetan PLANTEFEVE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de DIJON</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jean Pierre QUENOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital RAYMOND POINCARE</name>
      <address>
        <city>Garches</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Paris MENG</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHD de VENDEE</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>ESNAULT Jean Luc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de LA ROCHELLE</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>RONCATO-SABERAN Mariam</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital de La Timone</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Marc GAINNIER</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord de Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Laurent PAPAZIAN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de MONTAUBAN</name>
      <address>
        <city>Montauban</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Frederic BELLEC, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de NANTES</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>RAFFI François</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR d'ORLEANS</name>
      <address>
        <city>Orléans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Toufik KAMEL</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de POITIERS</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>LE MOAL Gwenaël</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de STRASBOURG</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>REY David</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de STRASBOURG NHC</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Julie BOISRAME-HELMS, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU de TOURS</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>BERNARD Louis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>side effects</keyword>
  <keyword>decision making</keyword>
  <keyword>indications</keyword>
  <keyword>risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

